These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 978769)

  • 21. Antitumor antibodies and immunoglobulin class and subclass levels in Corynebacterium parvum-treated mice.
    James K; Willmott N; Milne I; McBride WH
    J Natl Cancer Inst; 1976 May; 56(5):1035-40. PubMed ID: 825650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection of mice against intestinal amoebiasis with BCG, Corynebacterium parvum and Listeria monocytogenes.
    Ghadirian E; Kongshavn PA
    Parasite Immunol; 1986 Nov; 8(6):663-7. PubMed ID: 2880331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further analysis of the anti-tumour effect in vitro of peritoneal exudate cells from mice treated with Corynebacterium parvum.
    Ghaffar A; Cullen RT; Woodruff MA
    Br J Cancer; 1975 Jan; 31(1):15-24. PubMed ID: 1156505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of C. parvum on the number and activity of macrophages in primary and transplanted murine fibrosarcomas.
    McBride WH; Woodruff MF; Forbes GM; Moore K
    Br J Cancer; 1982 Sep; 46(3):448-51. PubMed ID: 7126431
    [No Abstract]   [Full Text] [Related]  

  • 25. In vivo transfer of antitumor activity by peritoneal exudate cells from mice treated with Corynebacterium parvum: reduced effect in irradiated recipients.
    Peters LJ; McBride WH; Mason KA; Hunter N; Basić I; Milas L
    J Natl Cancer Inst; 1977 Sep; 59(3):881-7. PubMed ID: 330869
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor-bearing mice.
    Wolmark N; Fisher B
    Cancer Res; 1974 Nov; 34(11):2869-72. PubMed ID: 4419513
    [No Abstract]   [Full Text] [Related]  

  • 27. Equipotent generation of protective antitumor immunity by various methods of dendritic cell loading with whole cell tumor antigens.
    Lambert LA; Gibson GR; Maloney M; Barth RJ
    J Immunother; 2001; 24(3):232-6. PubMed ID: 11394500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological effects of Corynebacterium parvum. 3. Amplification of resistance and impairment of active immunity to murine tumours.
    Smith SE; Scott MT
    Br J Cancer; 1972 Oct; 26(5):361-7. PubMed ID: 4343677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunity to transplantable nitrosourea-induced neurogenic tumors. I. Potentiation of tumor immunity with Corynebacterium parvum.
    Cravioto HM; DeBernardo E; Hochwald GM; Thorbecke JG
    J Neuropathol Exp Neurol; 1981 Sep; 40(5):526-36. PubMed ID: 7276992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of cell-mediated tumour immunity by Corynebacterium parvum.
    Kirchner H; Glaser M; Herberman R
    Nature; 1975 Oct; 257(5525):396-8. PubMed ID: 170531
    [No Abstract]   [Full Text] [Related]  

  • 31. Modification of radiation responses of murine tumors by misonidazole (Ro 07-0582), host immune capability, and Corynebacterium parvum.
    Stone HB; Milas L
    J Natl Cancer Inst; 1978 Apr; 60(4):887-93. PubMed ID: 633396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative studies of the immunostimulating (paramunizing) effectiveness of BCG, levamisole, Corynebacterium parvum and preparations of pock viruses in various in vivo and in vitro tests].
    Mayr A; Büttner M; Pawlas S; Erfle V; Mayr B; Brunner R; Osterkorn K
    Zentralbl Veterinarmed B; 1986 Jun; 33(5):321-39. PubMed ID: 2430381
    [No Abstract]   [Full Text] [Related]  

  • 33. The distribution and persistence in vivo of Corynebacterium parvum in relation to its antitumor activity.
    Scott MT; Milas L
    Cancer Res; 1977 Jun; 37(6):1673-9. PubMed ID: 870181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Active specific immunotherapy of mouse methylcholanthrene induced tumours with Corynebacterium parvum and irradiated tumour cells.
    Bomford R
    Br J Cancer; 1975 Nov; 32(5):551-7. PubMed ID: 1082344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of gold salts on tumour immunity and its stimulation by Corynebacterium Parvum.
    McBride WH; Tuach S; Marmion BP
    Br J Cancer; 1975 Nov; 32(5):558-67. PubMed ID: 813755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rejection of mammary adenocarcinoma cell tumors in DBA/2 mice immunocompromised by thymectomy and treatment with antithymocyte serum.
    Likhite VV
    J Immunol; 1975 Jun; 114(6):1736-42. PubMed ID: 1092759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative antitumor effects of Corynebacterium parvum, Bordetella pertussis, Bacillus Calmette-Guérin, and levamisole alone or in combination with cyclophosphamide in the CaD2 murine mammary adenocarcinoma system.
    Purnell DM; Bartlett GL; Kreider JW; Biro TG; Kontra J
    Cancer Res; 1979 Dec; 39(12):4838-42. PubMed ID: 498111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of transplanted methylcholanthrene induced fibrosarcomata and Corynebacterium parvum on the immune response of CBA and A-HeJ mice to thymus dependent and independent antigens.
    James K; Ghaffar A; Milne I
    Br J Cancer; 1974 Jan; 29(1):11-20. PubMed ID: 4820942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effect of Propionibacterium acnes on the growth on syngeneic tumor transplants in nude mice.
    Katahira SI; Kitamura H; Ito M; Minami K; Shigeta S
    Fukushima J Med Sci; 1979; 26(3-4):93-9. PubMed ID: 318050
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro antitumor effect of lymphoid cells from Corynebacterium parvum-treated mice: effect of route of C. parvum administration.
    Ghaffar A; Cullen RT
    J Natl Cancer Inst; 1977 Mar; 58(3):717-20. PubMed ID: 300113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.